To determine how histamine regulates endothelial barrier function through a
n integrative cytoskeletal network, we mathematically modeled the resistanc
e across an endothelial cell-covered electrode as a function of cell-cell,
cell-matrix, and transcellular resistances. Based on this approach, histami
ne initiated a rapid decrease in transendothelial resistance predominantly
through decreases in cell-cell resistance in confluent cultured human umbil
ical vein endothelial cells (HUVECs). Restoration of resistance was charact
erized by initially increasing cell-matrix resistance, with later increases
in cell-cell resistance. Thus histamine disrupts barrier function by speci
fically disrupting cell-cell adhesion and restores barrier function in part
through direct effects on cell-matrix adhesion. To validate the precision
of our technique, histamine increased the resistance in subconfluent HUVECs
in which there was no cell-cell contact. Exposure of confluent monolayers
to an antibody against cadherin-5 caused a predominant decrease in cell-cel
l resistance, whereas the resistance was unaffected by the antibody to cadh
erin-5 in subconfluent cells. Furthermore, we observed an increase predomin
antly in cell-cell resistance in ECV304 cells that were transfected with a
plasmid containing a glucocorticoid-inducible promoter controlling expressi
on of E-cadherin. Transmission electron microscopy confirmed tens of nanome
ter displacements between adjacent cells at a time point in which histamine
maximally decreased cell-cell resistance.